Moderna announces additional investments to increase global supply for COVID-19 vaccine to up to 3 billion doses in 2022

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to up to 3 billion doses of its COVID-19 vaccine,

from Breaking World Pharma News https://ift.tt/3nyyZnD